BPC-157, or Body Protection Compound 157, is a peptide known for its remarkable ability to promote healing and repair tissues
Lipo Mino Mix: Includes B6, Methionine, Inositol, Choline, B1, B2, and Carnitine
(2000), Horm Res 53(Suppl 3), PubMed 10971106 Statistics from preclinical literature AOD-9604 = modified fragment of hGH 177191 + N-terminal Tyr (sequence Tyr-Leu-Arg-Ile-Val-Gln-Cys-Arg-Ser-Val-Glu-Gly-Ser-Cys-Gly-Phe), molecular weight 1815.1 Da Developed at Metabolic Pharmaceuticals (Australia) based on the work of professor Frank Ng (Monash University) in the 1990s Standard experimental dose in obesity clinical trials: 1 mg/day subcutaneously (Phase 2b, Heffernan et al.) Mechanism: stimulation of 3-adrenergic receptors in adipose tissue, increased lipolysis and fatty acid oxidation without activation of the hGH receptor (no IGF-1 increase) Phase 2b clinical trial (2007, 300 patients): weight reduction ~2.8 kg vs placebo over 12 weeks FDA status: NDI rejection (2014) as a dietary supplement
If the 24-week trial could not demonstrate significant weight loss, there is no reason to believe that longer use would produce dramatically different results
J1100 covers dexamethasone sodium phosphate per 1mg, with units equal to milligrams administered